Clinical trialNCT04609904CompletedPhase 3Interventional

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

SponsorAstraZenecaEnrollment2,187Asthma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Robert Wise, MD
Johns Hopkins University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

317 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil

Research Site
Botucatu, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Santo André, Brazil
Research Site
Sorocaba, Brazil
Research Site
São Paulo, Brazil

China

Research Site
Baotou, China
Research Site
Beijing, China
Research Site
Changsha, China
Research Site
Changsha, China
Research Site
Changsha, China
Research Site
Changzhi, China
Research Site
Chengdu, China
Research Site
Chengdu, China
Research Site
Chizhou, China
Research Site
Chongqing, China
Research Site
Chongqing, China
Research Site
Dongguan, China
Research Site
Dongyang, China
Research Site
Fuzhou, China
Research Site
Guangzhou, China
Research Site
Guangzhou, China
Research Site
Guangzhou, China
Research Site
Guangzhou, China
Research Site
Guangzhou, China
Research Site
Guangzhou, China
Research Site
Haikou, China
Research Site
Haikou, China
Research Site
Hangzhou, China
Research Site
Hangzhou, China
Research Site
Hefei, China
Research Site
Hefei, China
Research Site
Hefei, China
Research Site
Huai'an, China
Research Site
Huizhou, China
Research Site
Jinan, China
Research Site
Jinhua, China
Research Site
Kunming, China

277 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BFF MDI 320/9.6 μgBFF pMDI 320/9 μgBGF MDI 320/14.4/9.6 μgBGF MDI 320/28.8/9.6 μg

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Mar 2021
Primary completion: 20 Mar 2025
Completion: 20 Mar 2025
Last update posted: 2 Jul 2026
Registered enrollment: 2,187
Registry id: NCT04609904

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-001521-31EU-CTR / CTIS (EudraCT)2023-505786-88

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.